Digital Health: Company presentation by Paul Hammer, BIOMES at the NOAH Conference Berlin 2019, 13-14 June, STATION.

1. Genomics-based
Healthcare Prevention
Well-being is coded in your DNA

2.  @NOAHConference
 @noah_conference
 @noah-conference
 @NOAHConference
FOLLOW USONSOCIAL

3. Do we have a Disease System and no Health System?
Health Unhealthy
2
• The health system only takes effect
when people become ill.
• This leads to a high burden on the
health system and society.
• Furthermore, there are lower
chances of achieving good results
for patients.
• Real-time screening of the health status
with sensors and biomarkers allows
early detection of disease formation
• Optimal adaptation of lifestyle based on
genetic and microbial background
Today‘s Problem

4. The digital and genomic revolution will change healthy living in
an unprecedented way.
3Confidential

5. Our mission
To empower people to live healthier lives by understanding their human &
microbial DNA and providing them with individualized health and wellness.
4

6. The 2nd Genome - The Microbiom?
5
What is microbiota?
Highly complex ecological community of commensal, symbiotic & pathogenic microorganisms.
100 trillion microbial cells living in and on parts of the human body like gut, skin, mouth, nose or genitals.
Outnumbering the human cells 10-fold and the human genome 150-fold.
Carries out important work the body cannot do itself and has a critical influence on health & wellbeing.
Consisting of bacteria, fungi, viruses and archaea.

7. What Is Microbiota Good For?
INDISPENSABLE FOR
HEALTH AND WELLBEING
REGULATES
mood, health and wellbeing
INFLUENCES
body weight and the
calories you harvest
FACILITATES
digestion & nutrient
uptake
TEACHES
the immune system
PROTECTS
against harmful
microorganisms
SYNTHESIZES
vitamins, including B12, K
and Folate
B12
K
C19H19N7O6
6

8. INTEST.pro: our first consumer product
INTEST.pro is an easy-to-use collection kit
that can be used comfortably and
privately at home.
Gut flora analysis
Information about one‘s own
microorganisms, along with personalized
recommendations on how to improve
one‘s own microbiota.
Detailed report with recommendations
7

9. How Does It Work?
1 2 3 4 5 6
Customer
buys
INTEST.pro
Customer
takes a
sample
Customer sends
sample back to
BIOMES
Microbiome
extraction &
NGS analysis
Profile exploration,
including
personalized
recommendations
for the customer
Data processing
& result
matching
8

10. What’s in Each Customer’s Report?
9
Report features:
Immune system and wellbeing
Vitamin synthesis
Calorie harvest
Gut microbiome balance
Food intolerances
Digestion & nutrition uptake
Intestinal mucosa
Personalized nutrition plans
Personalized probiotic supplements

11. The Benefits of our Process
INTEST.pro is a quantum leap compared to
classical intestinal flora analysis.
Measure and quantify the
totality of microbes.
2.5B
3.2B
unprecedented depth of analysis made possible
with DNA sequencing
with minimal sample amount
unique, curated & proprietary knowledge database
(>6,000 studies)
personalized report based on the power of
community
individualized recommendations and personalized
nutrition plans
10

12. Where we help
PERFORMAN
CE & FITNESS
Fitness/Nutrition
Metabolic/Health
1
DIET &
NUTRITION
WEIGHT LOSS
& OBESITY
DIGESTION
PROBLEMS
IRRITABLE
BOWEL
SYNDROM
What’s wrong & why? How can you get better?
2 3 4 5
11
Wellbeing Spectrum

13. Huge Market Opportunity
by example of the e-Health market and Irritable bowel syndrome (IBS)
320
280
240
200
160
120
80
40
0
$ Billions
CAGR = 15.8%
2014 2016 2020 2021 2022
Global e-Health market will reach
€264 billion by 2022
e-Health: A hot global megatrend
Market potential given by IBS in Germany
15 million people in
Germany suffer from IBS
€ 1.94 billion market potential for
Germany
Additional huge market
potential through personalized
probiotics
Global Market volume of e-Health
12

14. Up-sale
Importance:
Additional business
Market potential:
Large
Duration:
Short-term
Informati
on
Knowledge
Data
Data & Knowledge
Importance:
Additional business
Market potential:
Very large
Duration:
Long-term
Business Model
Importance:
CORE BUSINESS
Market potential:
Very large
Duration:
Short-term
DNA Analyses
13
• Probiotic
Supplements
• Nutrition plans
• Lead provision

15. Fast Revenue Growth
14
• Fast growth by market occupation &
product diversification
• Online CAC at SEA, Facebook ~40 €
• Product sale after analytic ~35%
• Low COGS down to 10 € per analytic
(currently 20 €)
• Sales start in summer 2018 with > 250
k€ revenue
• Till June >350 k€ revenue in 2019
(>5.200 tests and >2.500 probiotics)
• 1.3 Mio. € revenue in 2019 with offline
sale deals and internationalization
(ENG, FR, ESP) -2.000.000 €
-1.500.000 €
-1.000.000 €
-500.000 €
0 €
500.000 €
1.000.000 €
1.500.000 €
2.000.000 €
2.500.000 €
3.000.000 €
3.500.000 €
- €
2.000.000 €
4.000.000 €
6.000.000 €
8.000.000 €
10.000.000 €
12.000.000 €
14.000.000 €
16.000.000 €
18.000.000 €
2018 2019 2020 2021 2022 2023
Revenue COGS Payroll Other expenses EBIT

16. Investment Ask
Product diversification
Internationalization –
Europe and Latin America
Marketing & sales activities
R&D and user interface
improvement
Investments already received:
Family & Friends
75k€ Oct 2016
EXIST sponsorship
160k€ Jun 2017
Seed round
600k€ Feb 2018
Funding amount
Up to 2 Mio. EUR by convertible loan (pre-A)
Up to 5 Mio. EUR for series A in Q3 2020
Up to 4 Mio. EUR by public promotion
programs (ProFIT)
Budget
allocation
Human resources
15

17. High Professional Team
Experienced
management team
Experienced
operational team
Dr. Paul Hammer
CEO & Founder
Andrej Wackerow
CCO & Co-Founder
Carsten Krumbiegel
CTO & Co-Founder
Christin Günther
CMO & Co-Founder
Dr. Tewodros Debebe Aklilu
Head of Science
Philipp Franke
Head of Laboratory
Jonas Dierenbach
Head of IT & Co-Founder
16

18. We are supported by
CONTACT
info@BIOMES.world
www.BIOMES.world
+49 163 474 15 31
Dr. Paul Hammer
We are awarded by
Alibaba Create
Cloud Contest
Jerusalem
Competition
Pitch Marathon